Cholesterol-independent effects of atorvastatin prevent cardiovascular morbidity and mortality in a mouse model of atherosclerotic plaque rupture

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)

Joep Perk, Guy De Backer, H. Gohlke et al. · European Heart Journal · 2012 · 8.5K citations · Full text

Medicine, Cardiology, Preventive Medicine +16

European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts)

Ian D. Graham, Dan Atar, K. Borch‐Johnsen et al. · European Heart Journal · 2007 · 3.8K citations · Full text

Medicine, Cardiology, Clinical Cardiology +14

Inflammation, Pravastatin, and the Risk of Coronary Events After Myocardial Infarction in Patients With Average Cholesterol Levels

Paul M. Ridker, Nader Rifai, Marc A. Pfeffer et al. · Circulation · 1998 · 1.4K citations

Medicine, Cardiology, Pharmacotherapy +17

Hyperlipidemia-Triggered Neutrophilia Promotes Early Atherosclerosis

Maik Drechsler, Remco T. A. Megens, Marc van Zandvoort et al. · Circulation · 2010 · 698 citations · Full text

Life Sciences, Immunology, Pathology +16

Divergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries

Jason L. Johnson, Sarah J. George, Andrew C. Newby et al. · Proceedings of the National Academy of Sciences · 2005 · 350 citations

Life Sciences, Cardiology, Cell Biology +14